researchers have developed a new artificial intelligence-based software which may identify and measure the severity of common causes of strokes and.

he said: "our research shows that people, on average, believe that only 34 per cent of protection claims are paid out by insurance companies...

erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.